Recent Posts

Post Market Surveillance for Medical Devices

The Essential Role of PMS in Ensuring Compliance with MDR 2017/745: A Professional Guide

‍Introduction to MDR 2017/745

The European Union’s Medical Device Regulation (MDR) 2017/745 represents a significant shift in the governing laws for medical devices. It is a comprehensive set of rules that focuses on the safety and performance of medical devices. The regulation was enacted in May 2017 and replaced two earlier directives, the Medical Device Directive (MDD) and the Active Implantable Medical Device Directive (AIMDD).

MDR 2017/745 covers a broad spectrum of medical devices, from simple bandages to the most complex diagnostic equipment. It sets forth stringent requirements for the design, manufacturing, and post-market surveillance of these devices. Furthermore, the regulation emphasizes the importance of a life-cycle approach to medical device safety, recognizing that safety and performance must be ensured not only before market release but also throughout the device’s lifecycle.

The significance of MDR 2017/745 lies in its aim to create a more robust, transparent, and sustainable regulatory framework for medical devices in Europe. The regulation enhances the level of patient safety and ensures the free and fair movement of medical devices within the European Union.

What is PMS (Post-Market Surveillance)?

Post Market Surveillance (PMS) is a systematic process implemented by manufacturers to actively and continuously monitor the safety and performance of a medical device after it has been released into the market. The primary objective of PMS is to ensure that any potential issues or risks associated with a medical device are identified and addressed promptly.

PMS involves the collection and evaluation of data from the clinical use of a medical device. It includes activities such as complaint handling, post-market clinical follow-up studies (PMCF), periodic safety update reports (PSUR), and trend reporting. The information gathered from these activities aids in the identification of any adverse events or changes in device performance, thus enabling prompt action to mitigate risks.

The importance of PMS lies in its ability to provide real-world evidence of a device’s safety and effectiveness. It bridges the gap between pre-market testing and actual use, offering valuable insights that can inform product improvements and innovations.

The Importance of PMS in Medical Device Regulation

In the context of medical device regulation, PMS plays a crucial role. It serves as a tool for regulatory authorities to ensure that medical devices on the market continue to meet the requisite safety and performance standards.

Through PMS, manufacturers are obliged to proactively collect and evaluate data relating to their devices’ performance in the post-market phase. This allows for the early detection of any potential safety issues, facilitating timely corrective or preventive actions. The feedback loop provided by PMS enables continuous improvement of devices, benefiting both manufacturers and end-users.

Furthermore, PMS contributes to the regulatory transparency sought by MDR 2017/745. It provides regulatory authorities, healthcare professionals, and patients with access to information about the real-world performance of medical devices. This transparency enhances trust in the medical device industry and contributes to patient safety.

The Relationship between MDR 2017/745 and PMS

MDR 2017/745 has significantly amplified the importance of PMS in the medical device industry. The regulation mandates a proactive and systematic approach to PMS, requiring manufacturers to establish, document, implement, and maintain a PMS system as part of their Quality Management System (Article 83).

Under MDR 2017/745, PMS is no longer a passive process of dealing with complaints as they arise. Instead, it is an active process of collecting and analyzing data to detect and address any issues related to the safety and performance of a medical device. It is a process that extends throughout the entire lifecycle of a device, from design and development to decommissioning.

The regulation further emphasizes the need for a PMS plan that outlines the strategies and methods for data collection and analysis. Manufacturers are required to demonstrate that they have a robust PMS system capable of identifying and managing risks associated with their devices.

Implementing PMS to Comply with MDR 2017/745

Implementation of a robust PMS system is essential for compliance with MDR 2017/745. The regulation necessitates that manufacturers have a clearly defined PMS plan (Article 84) detailing the processes and procedures for data collection, analysis, and reporting.

The PMS plan should be aligned with the risk management process and incorporate feedback into the product development cycle. It should include processes for complaint handling, trend reporting, and post market clinical follow-up. Moreover, the plan should detail how the manufacturer will use the data collected to continuously improve the safety and performance of the device.

Implementing a PMS system that complies with MDR 2017/745 (Article 83) requires a proactive approach. It involves setting up an effective feedback system to capture complaints and other post-market information and establishing processes to analyze this data and take appropriate action. It also requires manufacturers to regularly evaluate their PMS system and make improvements as necessary.

Key Steps for PMS under MDR 2017/745

Achieving compliance with MDR 2017/745 requires diligent implementation of PMS. Key steps in this process include the following:

  1. Develop a PMS Plan: The first step is to develop a comprehensive PMS plan (Article 84) that outlines the methods and processes for data collection and analysis. The plan should be tailored to the specific device and should take into account the risk profile, intended use, and user population.
  2. Implement a Feedback System: A systematic feedback system should be implemented to capture complaints and other post-market information. This system should be designed to gather data both proactively and reactively.
  3. Analyze Data: Data collected through the feedback system should be regularly analyzed to identify any trends or issues related to device safety or performance.
  4. Take Corrective and Preventive Actions: If the data analysis reveals any issues, appropriate corrective and preventive actions should be taken. This may include modifying the device design, updating the instructions for use, or even recalling the device if necessary.
  5. Document and Report: All PMS activities should be thoroughly documented in a PMS report (Article 85, class I devices) or PSUR (Article 86, not class I).

Challenges in PMS for MDR 2017/745

Implementing a robust PMS system in compliance with MDR 2017/745 can pose several challenges for manufacturers. One major challenge is the sheer volume of data that needs to be collected and analyzed. Managing this data and ensuring its quality and reliability can be a daunting task.

Another challenge lies in the integration of PMS with other systems such as risk management and quality management. Achieving this integration requires a holistic approach and strong coordination between different functions within the organization.

Furthermore, the proactive nature of PMS under MDR 2017/745 may require a shift in mindset for many manufacturers. Transitioning from a reactive approach to a proactive one can be a complex process that requires significant effort and resources.

Best Practices for PMS about MDR 2017/745

Despite the challenges, there are several best practices that manufacturers can adopt to effectively implement PMS in compliance with MDR 2017/745. These include:

  1. Adopting a Risk-Based Approach: The PMS system should be designed based on the risk profile of the medical device. Higher-risk devices will require more rigorous surveillance.
  2. Integrating PMS with Other Systems: PMS should not function in isolation. Instead, it should be integrated with other systems such as risk management and quality management. This integration will enable a holistic approach to device safety and performance.
  3. Investing in Technology: Investing in technology can greatly facilitate the implementation of PMS. Tools such as data analytics software can help manage and analyze the large volumes of data involved in PMS. Artificial intelligence (AI) can be of great support in collecting and analyzing data.
  4. Training and Education: Ensuring that all relevant personnel are adequately trained and educated about PMS is crucial. This includes not only those directly involved in PMS activities but also those in functions such as design, production, and marketing.

Case Studies of Successful PMS Implementation under MDR 2017/745

There are numerous examples of manufacturers who have successfully implemented PMS in compliance with MDR 2017/745. These case studies offer valuable insights and lessons for other manufacturers.

One such case study involves a manufacturer of cardiovascular devices. The company established a robust PMS system that included a comprehensive feedback system, regular data analysis, and proactive corrective and preventive actions. As a result, the company was able to identify and address several safety issues, leading to improvements in device performance and patient safety. Robust data can reduce the need for further PMCF studies and therefore reduce the resources required.

Another case study involves a manufacturer of orthopedic devices. The company integrated its PMS system with its risk management and quality management systems, enabling a holistic approach to device safety. This integration allowed the company to identify and address risks in a timely manner, leading to a reduction in adverse events.

Conclusion: The Essential Role of PMS in Ensuring Compliance with MDR 2017/745

In conclusion, PMS plays an essential role in ensuring compliance with MDR 2017/745. It represents a proactive approach to monitoring the safety and performance of medical devices in the post-market phase. By implementing a robust PMS system, manufacturers can effectively manage risks, improve device performance, and enhance patient safety.

While there are challenges involved in implementing PMS under MDR 2017/745, these can be overcome through diligent planning, the adoption of best practices, and the use of technology. The success stories of manufacturers who have successfully implemented PMS under MDR 2017/745 serve as a testament to the value and feasibility of this approach.

Are you ready to implement a robust PMS system and ensure compliance with MDR 2017/745?

Talk to our experts today!

Picture of Sobel Consultancy

Sobel Consultancy

Do Not Sell My Personal Information

© 2023 | All Rights Reserved


Alameda Santos, 1165
01419-002 Sao Paulo - SP

1309 Coffeen Avenue STE 1200
Sheridan, Wyoming 82801

Av. Engenheiro Duarte Pacheco, n 19 RC 54
1070-100 Lisboa

Select Your language